These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9863507)
1. Anti-HIV activity of N-1-adamantyl-4-aminophthalimide. Van Derpoorten K; Balzarini J; De Clercq E; Poupaert JH Biomed Pharmacother; 1997; 51(10):464-8. PubMed ID: 9863507 [TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant phenytoinergic pharmacophores and anti-HIV activity--preliminary evidence for the dual requirement of the 4-aminophthalimide platform and the N-(1-adamantyl) substitution for antiviral properties. Vamecq J; Van derpoorten K; Poupaert JH; Balzarini J; De Clercq E; Stables JP Life Sci; 1998; 63(19):PL267-74. PubMed ID: 9806229 [TBL] [Abstract][Full Text] [Related]
3. Isothiazole derivatives as novel HIV replication inhibitors. Cutrì CC; Garozzo A; Pannecouque C; Castro A; Guerrera F; De Clercq E Antivir Chem Chemother; 2004 Jul; 15(4):201-5. PubMed ID: 15457681 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of human immunodeficiency virus type (HIV-1) replication by some diversely functionalized spirocyclopropyl derivatives. Witvrouw M; Pannecouque C; De Clercq E; Fernández-Alvarez E; Marco JL Arch Pharm (Weinheim); 1999 May; 332(5):163-6. PubMed ID: 10366901 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles. Kritsanida M; Mouroutsou A; Marakos P; Pouli N; Papakonstantinou-Garoufalias S; Pannecouque C; Witvrouw M; De Clercq E Farmaco; 2002 Mar; 57(3):253-7. PubMed ID: 11989804 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4. Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Struyf S; Witvrouw M; Schols D; De Clercq E J Med Chem; 1999 Sep; 42(19):3971-81. PubMed ID: 10508445 [TBL] [Abstract][Full Text] [Related]
8. 1,2,5-Benzothiadiazepine and pyrrolo[2,1-d]-[1,2,5]benzothiadiazepine derivatives with specific anti-human immunodeficiency virus type 1 activity. Di Santo R; Costi R; Artico M; Massa S; Marongiu ME; Loi AG; De Montis A; La Colla P Antivir Chem Chemother; 1998 Mar; 9(2):127-37. PubMed ID: 9875384 [TBL] [Abstract][Full Text] [Related]
9. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of novel 4-substituted styryl quinazolines as potential antimicrobial agents. Modh RP; Patel AC; Mahajan DH; Pannecouque C; De Clercq E; Chikhalia KH Arch Pharm (Weinheim); 2012 Dec; 345(12):964-72. PubMed ID: 23018557 [TBL] [Abstract][Full Text] [Related]
12. Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro. Moog C; Aubertin AM; Kirn A; Luu B Antivir Chem Chemother; 1998 Nov; 9(6):491-6. PubMed ID: 9865387 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies on new DABOS: effect of substitutions at pyrimidine C-5 and C-6 positions on anti-HIV-1 activity. Sbardella G; Mai A; Artico M; Chimenti P; Massa S; Loddo R; Marongiu ME; La Collat P; Pani A Antivir Chem Chemother; 2001 Jan; 12(1):37-50. PubMed ID: 11437321 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, anti-HIV-1 activity, and modeling studies of N-3 Boc TSAO compound. Tomassi C; Nguyen VN; Marco-Contelles J; Balzarini J; Pannecouque C; De Clercq E; Soriano E; Postel D Bioorg Med Chem Lett; 2008 Apr; 18(7):2277-81. PubMed ID: 18353641 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, anti-human immunodeficiency virus activity and esterase lability of some novel carboxylic ester-modified phosphoramidate derivatives of stavudine (d4T). McGuigan C; Sutton PW; Cahard D; Turner K; O'Leary G; Wang Y; Gumbleton M; De Clercq E; Balzarini J Antivir Chem Chemother; 1998 Nov; 9(6):473-9. PubMed ID: 9865385 [TBL] [Abstract][Full Text] [Related]
16. [HIV-inhibiting activity of polyanion matrices and related substances containing adamantane and norbornene pharmacophores]. Timofeev DI; Perminova NG; Serbin AV; Kiseleva IaIu; Nekliudov VV; Vatolin GIu; Kas'ian LI; Grebinik TS; Timofeev IV Antibiot Khimioter; 2003; 48(5):33-41. PubMed ID: 12968467 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of antiproliferative effect of N-(alkyladamantyl)phthalimides in vitro. Horvat M; Uzelac L; Marjanović M; Cindro N; Franković O; Mlinarić-Majerski K; Kralj M; Basarić N Chem Biol Drug Des; 2012 Apr; 79(4):497-506. PubMed ID: 22176512 [TBL] [Abstract][Full Text] [Related]
18. Structure modifications of 6-aminoquinolones with potent anti-HIV activity. Tabarrini O; Stevens M; Cecchetti V; Sabatini S; Dell'Uomo M; Manfroni G; Palumbo M; Pannecouque C; De Clercq E; Fravolini A J Med Chem; 2004 Oct; 47(22):5567-78. PubMed ID: 15481992 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-HIV studies of 2- and 3-adamantyl-substituted thiazolidin-4-ones. Balzarini J; Orzeszko-Krzesińska B; Maurin JK; Orzeszko A Eur J Med Chem; 2009 Jan; 44(1):303-11. PubMed ID: 18420310 [TBL] [Abstract][Full Text] [Related]
20. Anti-AIDS agents. Part 61: Anti-HIV activity of new podophyllotoxin derivatives. Zhu XK; Guan J; Xiao Z; Cosentino LM; Lee KH Bioorg Med Chem; 2004 Aug; 12(15):4267-73. PubMed ID: 15246103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]